• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER PICCOLO OCCLUDER; OCCLUDER, PATENT DUCTUS, ARTERIOSUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER PICCOLO OCCLUDER; OCCLUDER, PATENT DUCTUS, ARTERIOSUS Back to Search Results
Model Number 9-PDAP-05-04-L
Device Problems Migration or Expulsion of Device (1395); Improper or Incorrect Procedure or Method (2017)
Patient Problem Embolism (1829)
Event Date 01/10/2020
Event Type  Injury  
Manufacturer Narrative
The results/method and conclusion codes along with investigation results will be provided in the final report.
 
Event Description
On (b)(6) 2020, a 4-2 amplatzer piccolo (lot # 6974979) was selected for implant for a (b)(6) month old (b)(6) kg patient with the following type a patent ductus arteriosus (pda) dimensions: 2.5mm minimal diameter, 5.8mm at the aortic end, and 7.2mm length.The device was placed and after multiple attempts, was determined mis-sized too small.The device was removed and exchanged for a 4-4 amplatzer piccolo (lot # 6800257), which was determined to be mis-sized too small as well.The 4-4 piccolo was removed and exchanged for a 5-4 piccolo (lot #7005306), which was placed across the pda.After an angiogram, it was decided the device closure was sufficient and showed no obstruction to pulmonary artery flow.The patient was returned to the nicu.On x-ray in the nicu it was found that the 5-4 piccolo device had embolized in the right pulmonary artery.The patient was immediately brought back to the cath lab and the 5-4 piccolo device was successfully removed using a 4 french glide cath and a 10mm gooseneck snare device.A 5-4 ado (lot # 7040697) device was placed and successfully implanted.
 
Manufacturer Narrative
Additional information: g4, g7, h2, h6 and h10.An event of embolization of the 05-04 piccolo device was reported.A 5/4 amplatzer duct occluder was later implanted.The results of the investigation are inconclusive since the device was not returned for analysis.A review of the measurements as reported from the field was performed.Per the sizing table in the instructions for use, arten600042307 version a, the correct size piccolo occluder for the measurements provided was 04-06, smaller than the embolized device.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.The cause of the reported event could not be conclusively determined.
 
Manufacturer Narrative
Correction information for d2.Additional information for g4, g7, h2, h10.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER PICCOLO OCCLUDER
Type of Device
OCCLUDER, PATENT DUCTUS, ARTERIOSUS
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
MDR Report Key9767075
MDR Text Key181827395
Report Number2135147-2020-00077
Device Sequence Number1
Product Code MAE
UDI-Device Identifier05415067031044
UDI-Public05415067031044
Combination Product (y/n)N
PMA/PMN Number
P020024
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 12/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/27/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/30/2024
Device Model Number9-PDAP-05-04-L
Device Catalogue Number9-PDAP-05-04-L
Device Lot Number7005306
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received11/10/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age3 MO
Patient Weight4
-
-